About the Authors

Michael Favorov

Affiliations International Vaccine Institute, Seoul, Korea, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America, Central Asia Office, Centers for Disease Control and Prevention, Almaty, Kazakhstan

Mohammad Ali

Affiliation International Vaccine Institute, Seoul, Korea

Aigul Tursunbayeva

Affiliation Kazakhstan National Tuberculosis Center, Almaty, Kazakhstan

Indira Aitmagambetova

Affiliation Central Asia Office, Centers for Disease Control and Prevention, Almaty, Kazakhstan

Paul Kilgore

Affiliation International Vaccine Institute, Seoul, Korea

Shakhimurat Ismailov

Affiliation Kazakhstan National Tuberculosis Center, Almaty, Kazakhstan

Terence Chorba

TLC2@cdc.gov

Affiliations Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America, Central Asia Office, Centers for Disease Control and Prevention, Almaty, Kazakhstan

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: MF IA PK. Performed the experiments: AT SI. Analyzed the data: MA AT SI. Contributed reagents/materials/analysis tools: IA PK TC. Wrote the paper: MF PK TC. Participated in critically revising the article for intellectual content: MF MA AT IA PK SI TC.